Development of an Assessment Tool for Completion by Patients with Overweight or Obesity.


Journal

Advances in therapy
ISSN: 1865-8652
Titre abrégé: Adv Ther
Pays: United States
ID NLM: 8611864

Informations de publication

Date de publication:
Jan 2023
Historique:
received: 01 09 2022
accepted: 22 09 2022
pubmed: 19 10 2022
medline: 25 1 2023
entrez: 18 10 2022
Statut: ppublish

Résumé

Discussions of weight-management strategies between patients and healthcare providers can yield positive outcomes for people with overweight or obesity. Nonetheless, people with overweight or obesity encounter communication challenges and other barriers to pursuing effective weight-management strategies with their healthcare providers. The aim of this study was to develop a new self-completed assessment tool to initiate and facilitate conversations related to weight management between patients and healthcare providers. Developing the assessment tool involved a series of steps and draft versions of the tool, based on feedback from key opinion leaders in the field of obesity (N = 4) and input from people with overweight or obesity (N = 18). Three iterative rounds of qualitative interviews were conducted in the USA. A targeted review of prior qualitative research was conducted to identify common and important impacts of obesity on patients' functioning. Standard qualitative analytical methods were used to identify concepts of importance in a concept elicitation exercise during the interviews and were evaluated for potential inclusion in the tool. Potential problems with the tool were flagged during cognitive debriefing of the draft tool. During 18 individual interviews, participants referenced the impact of their weight on their lives, including health and comorbidities, physical function, emotional/mental functioning, social life, and physical appearance. Over the course of the tool's development, 24 common and important impacts of obesity on patients' functioning were reduced to a final set of eight concepts in the final tool that were deemed important and relevant to both patients and key opinion leaders. The assessment tool is a five-item, self-completed measure expected to foster patient self-advocacy for individuals with overweight or obesity by giving them an opportunity to define their weight-management goals and discuss these, along with various medical interventions, with a healthcare provider.

Identifiants

pubmed: 36255649
doi: 10.1007/s12325-022-02334-8
pii: 10.1007/s12325-022-02334-8
pmc: PMC9579616
doi:

Types de publication

Journal Article

Langues

eng

Pagination

174-193

Informations de copyright

© 2022. The Author(s).

Références

Hales CM, Fryar CD, Carroll MD, Freedman DS, Aoki Y, Ogden CL. Differences in obesity prevalence by demographic characteristics and urbanization level among adults in the united states, 2013–2016. JAMA. 2018;319(23):2419–29.
doi: 10.1001/jama.2018.7270
Ward ZJ, Bleich SN, Cradock AL, et al. Projected U.S. state-level prevalence of adult obesity and severe obesity. N Eng J Med. 2019;381(25):2440–50.
Hales CM, Carroll MD, Fryar CD, Ogden CL. Prevalence of obesity and severe obesity among adults: United States, 2017–2018. NCHS Data Brief. 2020;360:1–8.
World Health Organization (WHO). Obesity and overweight. June 9, 2021. https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight . Accessed December 27, 2021.
Centers for Disease Control and Prevention. Adult obesity facts. September 30, 2021. https://www.cdc.gov/obesity/data/adult.html . Accessed December 27, 2021.
Garvey WT, Mechanick JI, Brett EM, et al; Reviewers of the AACE/ACE Obesity Clinical Practice Guidelines. American Association of Clinical Endocrinologists and American College of Endocrinology comprehensive clinical practice guidelines for medical care of patients with obesity. Endocr Pract. 2016;22(suppl 3):S1–S203.
Mechanick JI, Farkouh ME, Newman JD, Garvey WT. Cardiometabolic-based chronic disease, adiposity and dysglycemia drivers: JACC state-of-the-art review. J Am Coll Cardiol. 2020;75(5):525–38.
doi: 10.1016/j.jacc.2019.11.044
Mechanick JI, Garber AJ, Grunberger G, Handelsman Y, Garvey WT. Dysglycemia-based chronic disease: an American Association of Clinical Endocrinologists position statement. Endocr Pract. 2018;24(11):995–1011.
doi: 10.4158/PS-2018-0139
Mechanick JI, Hurley DL, Garvey WT. Adiposity-based chronic disease as a new diagnostic term: the American Association of Clinical Endocrinologists and American College of Endocrinology position statement. Endocr Pract. 2017;23(3):372–8.
doi: 10.4158/EP161688.PS
Frühbeck G, Busetto L, Dicker D, et al. The ABCD of obesity: an EASO position statement on a diagnostic term with clinical and scientific implications. Obes Facts. 2019;12(2):131–6.
doi: 10.1159/000497124
Kolotkin RL, Andersen JR. A systematic review of reviews: exploring the relationship between obesity, weight loss and health-related quality of life. Clin Obes. 2017;7(5):273–89.
doi: 10.1111/cob.12203
Kroes M, Osei-Assibey G, Baker-Searle R, Huang J. Impact of weight change on quality of life in adults with overweight/obesity in the United States: a systematic review. Curr Med Res Opin. 2016;32(3):485–508.
doi: 10.1185/03007995.2015.1128403
Haase CL, Lopes S, Olsen AH, Satylganova A, Schnecke V, McEwan P. Weight loss and risk reduction of obesity-related outcomes in 0.5 million people: evidence from a UK primary care database. Int J Obes (Lond). 2021;45(6):1249–58.
Fastenau J, Kolotkin RL, Fujioka K, Alba M, Canovatchel W, Traina S. A call to action to inform patient-centred approaches to obesity management: development of a disease-illness model. Clin Obes. 2019;9(3):e12309. https://doi.org/10.1111/cob.12309 .
doi: 10.1111/cob.12309
Agarwal M, Nadolsky K. Attitudes, perceptions, and practices among endocrinologists managing obesity. Endocr Pract. 2022;28(2):179–84.
doi: 10.1016/j.eprac.2021.10.006
Look M, Kolotkin RL, Dhurandhar NV, Nadglowski J, Stevenin B, Golden A. Implications of differing attitudes and experiences between providers and persons with obesity: results of the national ACTION study. Postgrad Med. 2019;131(5):357–65.
doi: 10.1080/00325481.2019.1620616
Kaplan LM, Golden A, Jinnett K, et al. Perceptions of barriers to effective obesity care: results from the national ACTION study. Obesity (Silver Spring). 2018;26(1):61–9. https://doi.org/10.1002/oby.22054 .
doi: 10.1002/oby.22054
Ruelaz AR, Diefenbach P, Simon B, Lanto A, Arterburn D, Shekelle PG. Perceived barriers to weight management in primary care–perspectives of patients and providers. J Gen Intern Med. 2007;22(4):518–22. https://doi.org/10.1007/s11606-007-0125-4 .
doi: 10.1007/s11606-007-0125-4
Rubino F, Puhl RM, Cummings DE, et al. Joint international consensus statement for ending stigma of obesity. Nat Med. 2020;26(4):485–97.
doi: 10.1038/s41591-020-0803-x
Walker RE, Kusch J, Fink JT, et al. Facilitating factors and barriers to weight management in women: physician perspectives. J Patient Cent Res Rev. 2018;5(1):18–27. https://doi.org/10.17294/2330-0698.1495 .
doi: 10.17294/2330-0698.1495
Kolotkin RL, Ervin CM, Meincke HH, Højbjerre L, Fehnel SE. Development of a clinical trials version of the Impact of Weight on Quality of Life-Lite questionnaire (IWQOL-Lite Clinical Trials Version): results from two qualitative studies. Clin Obes. 2017;7(5):290–9. https://doi.org/10.1111/cob.12197 .
doi: 10.1111/cob.12197
Kolotkin RL, Williams VSL, Ervin CM, et al. Validation of a new measure of quality of life in obesity trials: Impact of Weight on Quality of Life-Lite Clinical Trials Version. Clin Obes. 2019;9(3): e12310.
doi: 10.1111/cob.12310
Kolotkin RL, Williams VSL, von Huth SL, et al. Confirmatory psychometric evaluations of the Impact of Weight on Quality of Life-Lite Clinical Trials Version (IWQOL-Lite-CT). Clin Obes. 2021;11(5): e12477.
doi: 10.1111/cob.12477
Ervin CM, Whalley D, von Huth SL, Crawford R, Dine J, Fehnel SE. Development of the impact of weight on daily activities questionnaire: a patient-reported outcome measure. Clin Obes. 2020;10(6):e12387. https://doi.org/10.1111/cob.12387 .
doi: 10.1111/cob.12387
Miller K, Willson S, Chepp V, Padilla JL. Cognitive interviewing methodology. Hoboken (NJ): Wiley; 2014. Chapter 3, pp. 15–33. https://doi.org/10.1002/9781118838860 .
Willis GB. Cognitive interviewing. Thousand Oaks (CA): Sage; 2005. Chapter 12, pp. 226–288.

Auteurs

Nina Kim (N)

Novo Nordisk, Inc., 800 Scudders Mill Road, Plainsboro, NJ, 08536, USA.

T Michelle Brown (TM)

RTI Health Solutions, Research Triangle Park, NC, USA.

Chakkarin Burudpakdee (C)

Novo Nordisk, Inc., 800 Scudders Mill Road, Plainsboro, NJ, 08536, USA.

Chisom Kanu (C)

RTI Health Solutions, Research Triangle Park, NC, USA.

Krystene Woodard (K)

Novo Nordisk, Inc., 800 Scudders Mill Road, Plainsboro, NJ, 08536, USA. KYQW@novonordisk.com.

Sheri Fehnel (S)

RTI Health Solutions, Research Triangle Park, NC, USA.

Carrie Morrison (C)

Novo Nordisk, Inc., 800 Scudders Mill Road, Plainsboro, NJ, 08536, USA.

Joe Nadglowski (J)

Obesity Action Coalition, Tampa, FL, USA.

Karl Nadolsky (K)

Department of Diabetes & Endocrinology, Spectrum Health West Michigan, Michigan State University College of Human Medicine, Grand Rapids, MI, USA.

Ronette L Kolotkin (RL)

Quality of Life Consulting, Durham, NC, USA.
Department of Family Medicine and Community Health, Duke University School of Medicine, Durham, NC, USA.
Faculty of Health and Social Sciences, Western Norway University of Applied Sciences, Førde, Norway.
Centre of Health Research, Førde Hospital Trust, Førde, Norway.
Morbid Obesity Centre, Tønsberg, Norway.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH